Market Closed - Swiss Exchange 11:31:03 2024-05-29 EDT 5-day change 1st Jan Change
80 CHF -1.06% Intraday chart for Alcon Inc. -3.01% +21.82%

Financials

Sales 2024 * 9.99B 9.12B 13.69B Sales 2025 * 10.66B 9.74B 14.61B Capitalization 43.89B 40.06B 60.14B
Net income 2024 * 937M 855M 1.28B Net income 2025 * 1.21B 1.1B 1.65B EV / Sales 2024 * 4.69 x
Net Debt 2024 * 3B 2.74B 4.11B Net Debt 2025 * 1.73B 1.58B 2.37B EV / Sales 2025 * 4.28 x
P/E ratio 2024 *
48.3 x
P/E ratio 2025 *
39 x
Employees 25,000
Yield 2024 *
0.32%
Yield 2025 *
0.38%
Free-Float 98.58%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.10%
1 week-3.01%
Current month+12.46%
1 month+11.33%
3 months+6.36%
6 months+22.23%
Current year+21.82%
More quotes
1 week
79.86
Extreme 79.86
83.34
1 month
70.90
Extreme 70.9
83.34
Current year
62.24
Extreme 62.24
83.34
1 year
61.28
Extreme 61.28
83.34
3 years
55.22
Extreme 55.22
83.34
5 years
38.63
Extreme 38.625
83.34
10 years
38.63
Extreme 38.625
83.34
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 16-06-30
Director of Finance/CFO 56 19-04-07
Chief Tech/Sci/R&D Officer - 11-05-31
Members of the board TitleAgeSince
Chairman 68 18-06-30
Director/Board Member 65 18-12-31
Director/Board Member 60 19-01-31
More insiders
Date Price Change Volume
24-05-29 80 -1.06% 966 452
24-05-28 80.86 -1.73% 904,000
24-05-27 82.28 +0.32% 289,879
24-05-24 82.02 -0.89% 847,020
24-05-23 82.76 +0.39% 812,363

Delayed Quote Swiss Exchange, May 29, 2024 at 11:31 am

More quotes
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (56.7%): consumables (51.2% of net sales), implantable products (32%) and other products (16.8%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (43.3%): contact lenses (59.2% of sales) and eye care products (40.8%; eye drops and ophthalmic ointments, etc.) At the end of 2023, the group operated 19 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (46%), Japan (6.2%), China (5.6%) and other (41,5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
88.77 USD
Average target price
93.44 USD
Spread / Average Target
+5.26%
Consensus